Fibroblast growth factor (FGF23) polypeptides

US7745406B2 · kind B2 · utility

Assignees

• Advanced Research & Technology Institute · US
• Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik · DE

Inventors

• Michael Econs · Indianapolis, US
• Ken W. White · Ithaca, US
• Tim Matthias Strom · Munich, DE
• Thomas Meitinger · Munich, DE

Key dates

• Filing date: Nov 7, 2007
• Grant date: Jun 29, 2010
• Expiry date: Dec 20, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/172
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a kit for diagnosing a disorder comprising a reagent that detects FGF23 polypeptides and mutant FGF23 polypeptides.